Stock Market Reviews

Stock Ticker News

Get the latest news, insights, and market updates on all tickers. Explore the news page 15 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Dow Jones Futures Rise; AI Leader Climbs, Cancer-Test Firm Crashes; Trump Tariff Ruling Due?
  The stock market fell back on U.S.-Iran fears and other big headwinds. GE Aero led new buys, but there's no clear trend. Comfort Systems and Grail were big earnings movers.
  Feb 20, 2026 - $GE
• GE Vernova (GEV) Upgraded to Outperform as Energy Infrastructure Cycle Boosts Growth Prospects
  GE Vernova Inc. (NYSE:GEV) ranks among billionaire Stanley Druckenmiller’s 10 best stock picks. Baird upgraded GE Vernova Inc. (NYSE:GEV) to Outperform on February 4, stating that the firm is well-positioned to be among the largest beneficiaries of a growing energy-infrastructure cycle and that the market had misjudged the timing and magnitude of a potential surplus […]
  Feb 20, 2026 - $GEV
• GlobalFoundries (GFS), Renesas Electronics Announce Multi-Billion-Dollar Semiconductor Supply Chain Partnership
  GlobalFoundries Inc. (NASDAQ:GFS) is one of the best NASDAQ growth stocks to buy for the next 2 years. On February 16, GlobalFoundries and Renesas Electronics Corporation announced a multi-billion-dollar partnership to strengthen semiconductor supply chain resiliency. This collaboration expands Renesas’ access to GlobalFoundries’ specialized technology platforms, including FDX, BCD, and feature-rich CMOS technologies. The agreement […]
  Feb 20, 2026 - $GFS
• Compared to Estimates, Guardant Health (GH) Q4 Earnings: A Look at Key Metrics
  Although the revenue and EPS for Guardant Health (GH) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
  Feb 20, 2026 - $GH
• Guardant Health Inc (GH) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
  Guardant Health Inc (GH) reports a 39% revenue increase in Q4 2025, driven by oncology advancements and strategic expansions, despite ongoing cash flow challenges.
  Feb 20, 2026 - $GH
• Guardant Health Q4 Earnings Call Highlights
  Guardant Health (NASDAQ:GH) reported what executives described as a “breakout year” in 2025, driven by expanding capabilities across its oncology, screening, and biopharma/data businesses and continued progress toward profitability. On the company’s fourth-quarter 2025 earnings call, management hig
  Feb 20, 2026 - $GH
• Genmab (GMAB) Reports 19% Revenue Growth to $3.7B in 2025 Driven by Proprietary Medicine Sales
  Genmab (NASDAQ:GMAB) is one of the best NASDAQ growth stocks to buy for the next 2 years. On February 17, Genmab reported that its total revenue grew by 19% in 2025 to a total $3.7 billion. This growth was fueled by a 54% surge in sales of its proprietary medicines, most notably Abkinley, which generated […]
  Feb 20, 2026 - $GMAB
• Theft of Trade Secrets Is on the Rise—and AI Is Making It Worse
  Google, Apple and xAI are among companies that have sought to defend their sensitive information as employees are accused of stealing it.
  Feb 20, 2026 - $GOOG
• Alphabet (GOOGL) Gemini Adoption Surges, Canaccord Genuity Lifted Price Target on the Company
  Alphabet Inc. (NASDAQ:GOOGL) ranks among billionaire David Tepper’s 10 favorite stocks. Following the company’s solid fourth-quarter results, Canaccord Genuity raised its price target on Alphabet Inc. (NASDAQ:GOOGL) to $415 from $390 on February 5, maintaining a Buy rating on the shares. The tech giant announced total revenue that was about 2% higher than expected, owing […]
  Feb 20, 2026 - $GOOG
• The Zacks Analyst Blog Meta, NVIDIA, Alphabet and Snap
  META deepens its AI push with NVIDIA, but heavy 2026 spending and valuation concerns raise the question: buy now or wait?
  Feb 20, 2026 - $GOOG